Stephen Taub One of the Best-Performing Hedge Funds in Recent Years Just Got Richer Why Avoro Capital Advisors cheered Gilead’s deal to acquire Immunomedics. Stephen Taub September 16, 2020 (David Paul Morris/Bloomberg)